Literature DB >> 19539848

Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with a combination of isotretinoin and pamidronate.

Hassan Galadari1, Alyssa G Bishop, Suraj S Venna, Emad Sultan, Daihung Do, Ross Zeltser.   

Abstract

Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a clinically heterogeneous entity, encompassing a variety of debilitating conditions that have in common inflammation of the skeletal system and skin. To date, there is a paucity of documented efficacious treatment options. We report a 48-year-old man with skeletal and cutaneous signs and symptoms who improved dramatically after treatment with a combination of isotretinoin and pamidronate. This report provides an alternative treatment regimen for SAPHO that addresses the possible underlying pathophysiology of this likely underdiagnosed syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539848     DOI: 10.1016/j.jaad.2008.10.046

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  [Successful therapy of sacroiliitis in SAPHO syndrome by etanercept].

Authors:  Carola Wolber; Karin David-Jelinek; Astrid Udvardi; Gottfried Artacker; Beatrix Volc-Platzer; Herbert Kurz
Journal:  Wien Med Wochenschr       Date:  2011-01-25

2.  SAPHO syndrome with bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer.

Authors:  Katsuhiko Matsumaru; Kazuki Nagai; Takayuki Murakami; Kazuo Andoh
Journal:  BMJ Case Rep       Date:  2010-08-31

Review 3.  The effectiveness of treatments for patients with SAPHO syndrome: a follow-up study of 24 cases from a single center and review of literature.

Authors:  Hong Huang; Zhuoli Zhang; Juan Zhao; Yanjie Hao; Wei Zhou
Journal:  Clin Rheumatol       Date:  2020-08-13       Impact factor: 2.980

Review 4.  New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations.

Authors:  Wei Cheng; Fen Li; Jing Tian; Xi Xie; Jin-Wei Chen; Xiao-Fei Peng; Qi Tang; Yan Ge
Journal:  J Inflamm Res       Date:  2022-04-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.